[抗高血压和降脂治疗预防心脏病发作试验（ALLHAT研究）：主要抗高血压药物——利尿剂与钙通道阻滞剂与血管紧张素转换酶抑制剂的比较] - Suppr

Suppr

超能文献

[The ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial): primary antihypertensive agents - diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors].

作者信息

Scholze J, Unger Th

机构信息

Ambulante Spezialmedizin, Medizinische Poliklinik, Charité Berlin, Germany.

出版信息

Internist (Berl). 2003 Sep;44(9):1193-5. doi: 10.1007/s00108-003-1028-z.

DOI:10.1007/s00108-003-1028-z

PMID:14566471

Abstract

摘要

相似文献

[The ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial): primary antihypertensive agents - diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors].

Internist (Berl). 2003 Sep;44(9):1193-5. doi: 10.1007/s00108-003-1028-z.

Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

J Clin Hypertens (Greenwich). 2006 Dec;8(12):860-4. doi: 10.1111/j.1524-6175.2006.05781.x.

[Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].

Dtsch Med Wochenschr. 2003 Jan 31;128(5):214-6. doi: 10.1055/s-2003-36980.

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Circulation. 2006 May 9;113(18):2201-10. doi: 10.1161/CIRCULATIONAHA.105.544031. Epub 2006 May 1.

Update on the management of hypertension: recent clinical trials and the JNC 7.

J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):4-13. doi: 10.1111/j.1524-6175.2004.03830.x.

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Curr Hypertens Rep. 2003 Aug;5(4):293-4. doi: 10.1007/s11906-003-0036-7.

ALLHAT says diuretics are better; ANBP2 says ACEs are better--can we resolve the differences?

Cleve Clin J Med. 2004 Feb;71(2):145-50. doi: 10.3949/ccjm.71.2.145.

[The ALLHAT study: contributions, limitations and prospectives].

Ital Heart J Suppl. 2003 Feb;4(2):77-84.

Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.

Rep Med Guidel Outcomes Res. 2003 Jan 24;14(2):5-7.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.

Curr Hypertens Rep. 2004 Jun;6(3):212-4.

本文引用的文献

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

N Engl J Med. 2003 Feb 13;348(7):583-92. doi: 10.1056/NEJMoa021716.

The ALLHAT report: a case of information and misinformation.

J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):9-13. doi: 10.1111/j.1524-6175.2003.02287.x.

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8.

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.

Curr Control Trials Cardiovasc Med. 2002 Nov 14;3(1):10. doi: 10.1186/1468-6708-3-10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验